CYP2E1
Cytochrome P450 2E1
Also known as: CP2E1_HUMAN, CYP2E
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P05181
- Gene
- CYP2E1
- Ensembl
- ENSG00000130649
- Chromosome
- 10
- Canonical length
- 493 aa
- Protein class
- Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Mitochondria
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is induced by ethanol, the diabetic state, and starvation. The enzyme metabolizes both endogenous substrates, such as ethanol, acetone, and acetal, as well as exogenous substrates including benzene, carbon tetrachloride, ethylene glycol, and nitrosamines which are premutagens found in cigarette smoke. Due to its many substrates, this enzyme may be involved in such varied processes as gluconeogenesis, hepatic cirrhosis, diabetes, and cancer. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
493 residues, UniProt reviewed canonical sequence.
>P05181|CYP2E1
1 MSALGVTVAL LVWAAFLLLV SMWRQVHSSW NLPPGPFPLP IIGNLFQLEL KNIPKSFTRL
61 AQRFGPVFTL YVGSQRMVVM HGYKAVKEAL LDYKDEFSGR GDLPAFHAHR DRGIIFNNGP
121 TWKDIRRFSL TTLRNYGMGK QGNESRIQRE AHFLLEALRK TQGQPFDPTF LIGCAPCNVI
181 ADILFRKHFD YNDEKFLRLM YLFNENFHLL STPWLQLYNN FPSFLHYLPG SHRKVIKNVA
241 EVKEYVSERV KEHHQSLDPN CPRDLTDCLL VEMEKEKHSA ERLYTMDGIT VTVADLFFAG
301 TETTSTTLRY GLLILMKYPE IEEKLHEEID RVIGPSRIPA IKDRQEMPYM DAVVHEIQRF
361 ITLVPSNLPH EATRDTIFRG YLIPKGTVVV PTLDSVLYDN QEFPDPEKFK PEHFLNENGK
421 FKYSDYFKPF STGKRVCAGE GLARMELFLL LCAILQHFNL KPLVDPKDID LSPIHIGFGC
481 IPPRYKLCVI PRSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP2E1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 9,697 nTPM
Expression across tissuesHPA
Tissue
- liver: 9,697 nTPM
- tonsil: 32 nTPM
- esophagus: 16 nTPM
- skin: 13 nTPM
- cerebellum: 13 nTPM
- pancreas: 12 nTPM
Single-cell type
- hepatocytes: 7,807 nCPM
- esophageal apical cells: 173 nCPM
- hepatic stellate cells: 52 nCPM
- kupffer cells: 37 nCPM
- epididymal efferent duct absorptive cells: 30 nCPM
- retinal amacrine cells: 30 nCPM
Immune cell
- myeloid DC: 6.3 nTPM
- MAIT T-cell: 2.5 nTPM
- memory CD4 T-cell: 1.1 nTPM
- memory CD8 T-cell: 0.6 nTPM
- non-classical monocyte: 0.2 nTPM
- total PBMC: 0.2 nTPM
Brain region
- cerebellum: 14 nTPM
- white matter: 11 nTPM
- cerebral cortex: 9.3 nTPM
- pons: 9.1 nTPM
- thalamus: 8.1 nTPM
- medulla oblongata: 7.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CYP2E1.
Disease | ImmuneIEDB
Conditions an epitope on CYP2E1 was assayed in.
- drug-induced hepatitis B cell
- hepatitis C B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against CYP2E1 are reported. Each links to that disease's full target list.
Showing 1 of 2 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for CYP2E1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
21 publications
- Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
1996 · Mol Pharmacol · RCR 3.8 · 115 citations - Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury.
2008 · Trends Mol Med · RCR 2 · 70 citations - Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics.
1999 · Mol Pharmacol · RCR 1.5 · 51 citations - CYP2E1 autoantibodies in liver diseases.
2014 · Redox Biol · RCR 1.3 · 35 citations - Increased serum anti-CYP2E1 IgG autoantibody levels may be involved in the pathogenesis of occupational trichloroethylene hypersensitivity syndrome: a case-control study.
2022 · Arch Toxicol · RCR 1.3 · 12 citations
Show 16 more
- Immune mechanisms in alcoholic liver disease.
2010 · Genes Nutr · RCR 1.3 · 43 citations - Role of adaptive immunity in alcoholic liver disease.
2012 · Int J Hepatol · RCR 1.1 · 34 citations - Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease.
2003 · Hepatology · RCR 1.1 · 44 citations - Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis.
2006 · Clin Vaccine Immunol · RCR 0.8 · 28 citations - Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies.
2007 · Anesth Analg · RCR 0.7 · 20 citations - Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury.
2009 · Eur J Immunol · RCR 0.6 · 24 citations - Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry.
2010 · J Hepatol · RCR 0.5 · 13 citations - Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C.
2007 · J Hepatol · RCR 0.4 · 15 citations - Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis.
2018 · mSphere · RCR 0.4 · 6 citations - [Overview of occupational diseases induced by trichloroethylene and associated basic research].
2023 · Sangyo Eiseigaku Zasshi · RCR 0.3 · 1 citations - Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C.
2009 · Am J Transplant · RCR 0.2 · 8 citations - Non-positive autoimmune responses against CYP2E1 in refrigeration mechanics exposed to halogenated hydrocarbons.
2007 · Sci Total Environ · RCR 0.1 · 2 citations - Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C.
2010 · J Viral Hepat · RCR 0.1 · 2 citations - CYP2E1 immunoglobulin G4 subclass antibodies after desflurane anesthesia.
2014 · World J Hepatol · RCR 0 · 1 citations - Immune effects of trichloroethylene: key findings of occupational hypersensitivity syndrome and its pathogenesis.
2026 · Arch Toxicol - Clinical discovery of anti-CYP2E1 autoantibodies and preclinical efficacy of a CYP2E1 inhibitor in rheumatoid arthritis.
2026 · Drug Metab Dispos
Reference: B cellIEDB
1 publication
- Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis.
2018 · mSphere · RCR 0.4 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.17
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.88
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- epoxygenase P450 pathway
- lipid hydroxylation
- long-chain fatty acid biosynthetic process
- long-chain fatty acid metabolic process
- monoterpenoid metabolic process
- response to bacterium
- steroid metabolic process
- xenobiotic metabolic process
- 4-nitrophenol metabolic process
- benzene metabolic process
- carbon tetrachloride metabolic process
- halogenated hydrocarbon metabolic process
Molecular functions
- arachidonate epoxygenase activity
- enzyme binding
- heme binding
- Hsp70 protein binding
- Hsp90 protein binding
- iron ion binding
- long-chain fatty acid omega-1 hydroxylase activity
- monooxygenase activity
- oxidoreductase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
- oxygen binding
- 4-nitrophenol 2-monooxygenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cytochrome P450
- Cytochrome P450, E-class, group I
- Cytochrome P450, conserved site
- Cytochrome P450 superfamily
- Cytochrome P450 family 2
- Cytochrome P450
- Cytochrome P450, E-class, group I, CYP2E-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CYP2E1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- HSP90
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP2E1 as an antibody target. Whether an autoantibody or antibody against CYP2E1 could matter depends on whether native CYP2E1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP2E1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP2E1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...